<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04107701</url>
  </required_header>
  <id_info>
    <org_study_id>P00029918</org_study_id>
    <secondary_id>R01ES030100</secondary_id>
    <nct_id>NCT04107701</nct_id>
  </id_info>
  <brief_title>Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD</brief_title>
  <acronym>AeroBPD</acronym>
  <official_title>Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators want to learn the role of indoor environmental exposures on respiratory
      symptoms, and, separately, on lung function deficits in school-aged children with
      bronchopulmonary dysplasia (BPD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bronchopulmonary dysplasia (BPD) is the most common respiratory disease affecting children
      born prematurely and leads to long-term respiratory symptoms and lung function impairment
      throughout childhood. This study will, evaluate the contribution of indoor sources of
      respiratory irritants to respiratory health impairment in school-aged children with BPD.
      State-of-the-art measures of indoor air quality constituents will assess the relationship of
      nitrogen dioxide (NO2), particulate matter (PM2.5), as well as, concentrations of allergens
      (mold, mouse, cockroach, pet), endotoxin, air temperature and humidity with concurrently
      measured respiratory symptoms and lung function in a well-characterized cohort of children
      with BPD. This research will identify specific harmful components of the indoor environment
      associated with respiratory morbidity and poor lung function in children with BPD.

      Investigators will ask the participants to come in for a one time clinic visit for undergoing
      procedures as well as answering questions regarding health and home environment. During the 1
      year of participation there will also be 2 home assessment visits where investigators will
      take a sample of the home environment as well record home characteristics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 22, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory Morbidity</measure>
    <time_frame>2 weeks</time_frame>
    <description>maximum symptom days in the prior 2 weeks assessed at completion of home sampling visits ( Units: days scale: 0-14 days with symptoms, higher is worse</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lung Function</measure>
    <time_frame>1 yr</time_frame>
    <description>Spirometry (FEV1 percent predicted) Units: percent Scale: continuous integers, higher is better</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung function</measure>
    <time_frame>1 year</time_frame>
    <description>Oscillometry (R5-20)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function</measure>
    <time_frame>1 year</time_frame>
    <description>Oscillometry (AX) units: cmH20 scale 0 - infinity, lower is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function</measure>
    <time_frame>1 year</time_frame>
    <description>Oscillometry R5 units: cmH20 scale 0 - infinity, lower is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function</measure>
    <time_frame>1 year</time_frame>
    <description>Oscillometry R5-20 units: cmH20 scale 0 - infinity, lower is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function</measure>
    <time_frame>1 year</time_frame>
    <description>Oscillometry X5 units: cmH20 scale 0 - infinity, lower is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function</measure>
    <time_frame>1 year</time_frame>
    <description>Oscillometry Fres units: Hz scale 0 - infinity, lower is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung Function</measure>
    <time_frame>1 year</time_frame>
    <description>FEV1/FVC units: percent scale: continuous integer, higher is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung Function</measure>
    <time_frame>1 year</time_frame>
    <description>FVC percent predicted units: percent scale: continuous integer, higher is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung Function</measure>
    <time_frame>1 year</time_frame>
    <description>FEF25-75 percent predicted units: percent scale: continuous integer, higher is better</description>
  </secondary_outcome>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <condition>Chronic Lung Disease of Newborn</condition>
  <condition>Environmental Exposure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Children 6-12 years with BPD in MA
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children 6-12 yrs old

          -  born &lt;32 wks gestational age

          -  diagnosis of BPD or &gt; 28 days of oxygen or respiratory support

        Exclusion Criteria:

          -  major airway or chest surgery

          -  physical or mental impairment that will prevent from doing spirometry

          -  plans to move out of state within the next 9 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jonathan Gaffin, MD. MMSc.</last_name>
    <phone>857-218-5336</phone>
    <email>jonathan.gaffin@childrens.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amparito Cunningham, MD. MPH.</last_name>
    <phone>857-218-5336</phone>
    <email>amparito.cunningham@childrens.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Childrens Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Gaffin, MD. MMSc.</last_name>
      <phone>857-218-5336</phone>
      <email>jonathan.gaffin@childrens.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Amparito Cunningham, MD. MPH.</last_name>
      <phone>8572185336</phone>
      <email>amparito.cunningham@childrens.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jonathan Gaffin, MD. MMSc.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 24, 2019</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2019</study_first_posted>
  <last_update_submitted>September 25, 2019</last_update_submitted>
  <last_update_submitted_qc>September 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Jonathan M. Gaffin</investigator_full_name>
    <investigator_title>Principal Investigator, Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>BPD</keyword>
  <keyword>bronchopulmonary dysplasia</keyword>
  <keyword>children and environment</keyword>
  <keyword>environment</keyword>
  <keyword>bronchopulmonary dysplasia and environment</keyword>
  <keyword>environment and children</keyword>
  <keyword>chronic lung disease of newborn</keyword>
  <keyword>environment and chronic lung disease of the newborn</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

